Kevin A Ault

Summary

Affiliation: Emory University
Country: USA

Publications

  1. doi request reprint Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine
    Kevin A Ault
    Department of Gynecology and Obstetrics and the Emory Vaccine Center, Atlanta, GA 30303, USA
    Int J Cancer 128:1344-53. 2011
  2. doi request reprint Human papillomavirus vaccines: an update for gynecologists
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:527-32. 2008
  3. doi request reprint New antibiotics and vaccines in obstetric practice. Foreword
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:485. 2008
  4. ncbi request reprint Long-term efficacy of human papillomavirus vaccination
    Kevin A Ault
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Drive, Atlanta, GA 30064, USA
    Gynecol Oncol 107:S27-30. 2007
  5. ncbi request reprint Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, SE, Atlanta, GA 30303, USA
    Lancet 369:1861-8. 2007
  6. doi request reprint Programmatic and research priorities for improving influenza immunization of pregnant women
    Kevin A Ault
    Department of Gynecology and Obstetrics and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA
    Am J Obstet Gynecol 207:S75-7. 2012
  7. ncbi request reprint Human papillomavirus vaccines and the potential for cross-protection between related HPV types
    Kevin A Ault
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, S E Atlanta, Georgia 30303, USA
    Gynecol Oncol 107:S31-3. 2007
  8. pmc Epidemiology and natural history of human papillomavirus infections in the female genital tract
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
    Infect Dis Obstet Gynecol 2006:40470. 2006
  9. ncbi request reprint Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Obstet Gynecol Surv 61:S26-31. 2006
  10. ncbi request reprint A controlled trial of a human papillomavirus type 16 vaccine
    Laura A Koutsky
    Department of Epidemiology, University of Washington, Seattle, USA
    N Engl J Med 347:1645-51. 2002

Detail Information

Publications18

  1. doi request reprint Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine
    Kevin A Ault
    Department of Gynecology and Obstetrics and the Emory Vaccine Center, Atlanta, GA 30303, USA
    Int J Cancer 128:1344-53. 2011
    ..In summary, our findings show that AIS evades colposcopic and cervical cytologic detection. As most AIS lesions were HPV16/18-related, prophylactic HPV vaccination should reduce the incidence of invasive adenocarcinoma...
  2. doi request reprint Human papillomavirus vaccines: an update for gynecologists
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:527-32. 2008
    ..This review will discuss the natural history and epidemiology of HPV, the diseases associated with these infections and current clinical usage of this vaccine. Future developments in this area will also be discussed...
  3. doi request reprint New antibiotics and vaccines in obstetric practice. Foreword
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:485. 2008
  4. ncbi request reprint Long-term efficacy of human papillomavirus vaccination
    Kevin A Ault
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Drive, Atlanta, GA 30064, USA
    Gynecol Oncol 107:S27-30. 2007
    ..Population-based long-term efficacy trials conducted in these countries aim to investigate the long-term efficacy of HPV vaccination with regard to invasive cervical cancer, and the results of these trials are awaited with interest...
  5. ncbi request reprint Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, SE, Atlanta, GA 30303, USA
    Lancet 369:1861-8. 2007
    ..In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases...
  6. doi request reprint Programmatic and research priorities for improving influenza immunization of pregnant women
    Kevin A Ault
    Department of Gynecology and Obstetrics and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA
    Am J Obstet Gynecol 207:S75-7. 2012
    ..The 2009 influenza pandemic was accompanied by increased maternal vaccination rates. In this article, we review programmatic and research priorities with regard to overcoming barriers to influenza immunization of pregnant women...
  7. ncbi request reprint Human papillomavirus vaccines and the potential for cross-protection between related HPV types
    Kevin A Ault
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, S E Atlanta, Georgia 30303, USA
    Gynecol Oncol 107:S31-3. 2007
    ..Over a period of 6 months, cross-protection was observed against persistent infections with HPV-45, -31 and -52, and at 12 months, modest protection was demonstrated against persistent infections with 12 combined oncogenic HPV types...
  8. pmc Epidemiology and natural history of human papillomavirus infections in the female genital tract
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
    Infect Dis Obstet Gynecol 2006:40470. 2006
    ..New prophylactic HPV vaccines promise to dramatically reduce the incidence of HPV infection, genital warts, and cytologic abnormalities...
  9. ncbi request reprint Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review
    Kevin A Ault
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Obstet Gynecol Surv 61:S26-31. 2006
    ....
  10. ncbi request reprint A controlled trial of a human papillomavirus type 16 vaccine
    Laura A Koutsky
    Department of Epidemiology, University of Washington, Seattle, USA
    N Engl J Med 347:1645-51. 2002
    ..Although most infections are benign, some progress to anogenital cancer. A vaccine that reduces the incidence of HPV-16 infection may provide important public health benefits...
  11. ncbi request reprint Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
    Luisa L Villa
    Department of Virology, Ludwig Institute for Cancer Research, R Prof Antonio Prudente 109, 4th Floor, 01509 010 Sao Paulo, SP, Brazil
    Vaccine 24:5571-83. 2006
    ..Following an initial, similar sized decline, anti-HPV responses plateaued and remained stable through end-of-study (3.0 years). No vaccine-related serious adverse experiences were reported...
  12. ncbi request reprint Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial
    Constance Mao
    Department of Obstetrics and Gynecology and Epidemiology, University of Washington, Seattle, Washington 98104 2499, USA
    Obstet Gynecol 107:18-27. 2006
    ..Whether protection lasts longer than 18 months and, thus, impacts rates of cervical intraepithelial neoplasia (CIN) 2-3 has not yet been established. We present results from an HPV16 L1 VLP vaccine trial through 48 months...
  13. ncbi request reprint Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
    Luisa L Villa
    Department of Virology, Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Lancet Oncol 6:271-8. 2005
    ....
  14. ncbi request reprint A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
    Kevin A Ault
    Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Vaccine 22:3004-7. 2004
    ..Peak anti-HPV18 geometric mean titers (GMT) in vaccines were 60-fold greater than those observed in women following natural HPV18 infection. Further studies of a multivalent HPV L1 VLP vaccines are warranted...
  15. pmc Does rubella immunity predict measles immunity? A serosurvey of pregnant women
    Colleen M Kennedy
    Department of Obstetrics and Gynecology, Roy J and Lucille A Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
    Infect Dis Obstet Gynecol 2006:13890. 2006
    ..This study was undertaken to determine whether rubella immunity infers measles immunity in pregnant women...
  16. pmc Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists
    Janice C Raley
    Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
    Infect Dis Obstet Gynecol 12:127-33. 2004
    ..Vaccination for HPV may become a routine part of office gynecology. We surveyed members of the American College of Obstetricians and Gynecologists (ACOG) to determine their attitudes to HPV vaccination...
  17. ncbi request reprint Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine
    Kevin A Ault
    Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Obstet Gynecol Clin North Am 30:809-17. 2003
    ..Gynecologists should be familiar with these therapies and their potential short-comings. A recently reported clinical trial has raised hopes that HPV and its sequelae may be prevented by vaccination...
  18. ncbi request reprint Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine
    Christophe Fraser
    Imperial College London, London, UK
    Vaccine 25:4324-33. 2007
    ....